# Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)

> **NCT03297814** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sophia Al-Adwan** · enrollment: 20 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **BIOLOGICAL:** Platelet lysate
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03297814
- **Lead sponsor:** Sophia Al-Adwan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-18
- **Primary completion:** 2020-03
- **Final completion:** 2020-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297814, "Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03297814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*